Drug Repurposing for Targeting ISL LIM Homeobox 2 in Treatment of Endometriosis: A Computational Study.
Although these six drugs appear to be promising candidates for modulating endometriosis, Ivermectin is more likely to effectively inhibit ISL2.
Authors
- Soodeh Mahdian (ORCID: https://orcid.org/0000-0003-1967-4868)
- Maryam Shahhoseini (ORCID: https://orcid.org/0000-0002-9021-6408)
- Raha Favaedi
- Gelareh Mikaeeli
- Ashraf Moini (ORCID: https://orcid.org/0000-0002-5074-2286)
Institutions
- Royan Institute (IR)
- University of Tehran (IR)
- Academic Center for Education, Culture and Research (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- PubMed
- Published
- 2025-05-14
- DOI
- https://doi.org/10.22074/ijfs.2025.2009299.1516
- Primary Topic
- Macrophage Migration Inhibitory Factor
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Science Foundation
- Iran National Science Foundation
- Royan Institute